A new study provides clues that could enhance physicians’ ability to pinpoint, in real-time, which patients are not responding to therapy — and intervene with additional drugs to boost the chances of shrinking tumors.
A new study provides clues that could enhance physicians’ ability to pinpoint, in real-time, which patients are not responding to therapy — and intervene with additional drugs to boost the chances of shrinking tumors.